Infinitus is a Healthcare AI communication company that automates routine calls for leading brands. With their digital assistant Eva, healthcare companies can offload thousands of benefit verification, prior authorization, and pharmacy calls per day. Their AI solution automates benefit verification, prior authorization follow-up, and prescription follow-up calls to payors and pharmacy benefit managers on behalf of healthcare providers.

Ankit Jain

Shyamsundar Rajagopalan

Infinitus Systems, Inc.

AKASA leverages revenue cycle management expertise and technology, including generative AI, to enhance the revenue cycle in healthcare, focusing on improving efficiency and patient satisfaction. Self-described as the preeminent provider of generative AI solutions for the healthcare revenue cycle.

AKASA

Infinitus is a Healthcare AI communication company that automates routine calls for leading brands. With our digital assistant Eva, healthcare companies can offload thousands of benefit verification, prior authorization, and pharmacy calls per day. Infinitus automates calls between entities such as Pharmacies, Patient Access Programs, Hospitals, Providers, and Payors, enabling the US healthcare system to spend less time on hold and more time improving the patient experience.

Coatue

Kleiner Perkins

Tau Ventures

Firebolt Ventures

Gradient Ventures

Quiet Capital

Aparna Chennapragada

Gokul Rajaram

Ian Goodfellow

Qasar Younis

Google Ventures

Operator Partners

Aashima Gupta

"You can have a thousand ideas, but you can’t deliver on them unless you have the people that can build on those ideas and execute on them." - Infinitus CEO and Co-Founder Ankit Jain  

Infinitus wouldn't be here without the dedication, passion, and relentless pursuit of innovation from our team. Thank you, Infinauts, for everything you do to build a better healthcare future 🚀

#EmployeeAppreciationDay #ThankYouTeam

This Rare Disease Day, we're raising awareness about rare diseases, their impact on patients' lives, and the barriers to treatment they often face. 

At Infinitus we're working to do our part to reduce this barrier with faster access to necessary therapies for those who need them.

#RareDiseaseDay #Awareness 

🌟 On this Rare Disease Day, I'm inspired to share a story that's very close to my heart. It's about resilience, hope, and the incredible journey of my daughter, a rare disease warrior. 🌟

Just a few years ago, our lives were turned upside down when my Reyna was diagnosed with congenital hyperinsulinism. Her blood sugars dropped critically low, three doctors didn't quite know what was going on and we felt hopeless. Once we started understanding her condition (thank you Krishna, Archana and so many others for helping us open doors, get answer), we took her to CHOP, enrolled her in a clinical trial, performed a 21% pancreatectomy which finally led to her being cured of HI. 

Through all of this, Reyna showed an unwavering spirit that taught us the true meaning of strength. I still remember seeing her the day after her surgery as she woke up and wondering how she was smiling at the sight of us. 

Her journey wasn't easy, but it has been profoundly inspiring. After an uneventful few years, we may have another rare healthcare journey upon us but we are entering it with the hope that we can go through it with the same strength with such  we went through the first one. 

Today, I want to honor my daughter's resilience and shine a light on the rare disease community. These warriors face unimaginable challenges every day, yet they confront them with courage that is nothing short of awe-inspiring.

Let's use Rare Disease Day to raise awareness, foster understanding, and extend our support to those living with rare diseases and their families. Every story of struggle, every step towards progress, and every victory, no matter how small, deserves to be celebrated.

To everyone in the rare disease community, you are not alone. Your strength inspires the world, and together, we can bring about change. Here's to hope, healing, and the incredible journey ahead. 💖

#RareDiseaseDay #Hope #Resilience #Awareness #Support

"It was that moment of inspiration that made us go: There's something real here. Let's go build it."

This month, Infinitus celebrated our fifth birthday 🎉 and Co-Founders Ankit Jain and Shyam Rajagopalan took time to reflect on the journey from the very first payor call (and immediately getting hung up on) to where we are today. 


We're thrilled to announce our AI partnership with Infinitus Systems, Inc. to accelerate time to therapy and generate incremental cost savings. See more: https://lnkd.in/ehmPNFyb

#pharma #digitalhealth #aibusiness #aihealth #aihealth 

Metric
Company Name	Infinitus Systems, Inc.	AKASA
Symbol
MSH ID	AI:INFINITUS	COM:AKASA
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Healthcare Technology
Country	US	US
Stage	Series C	Series C
Employee Count	171
Website	infinitus.ai	akasa.com
LinkedIn	infinitusai	akasahealth
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	8.23K	2.12K
Web Traffic Growth	1.06	-0.60
Valuation
Raised Capital	51.50M	120M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AI:INFINITUS

Infinitus Systems, Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue